| Jo Ann Meyer, MD | |
|
517 Catalpa St, Monroe, LA 71201-7426 | |
| (318) 966-8343 | |
| (318) 966-8345 |
| Full Name | Jo Ann Meyer |
|---|---|
| Gender | Female |
| Speciality | Ophthalmology |
| Experience | 31 Years |
| Location | 517 Catalpa St, Monroe, Louisiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063693406 | NPI | - | NPPES |
| 187244001 | Medicaid | AR | |
| 1495123 | Medicaid | LA | |
| 41947 | Other | FL | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | ME73406 (Florida) | Secondary |
| 207W00000X | Ophthalmology | MD021987 (Louisiana) | Primary |
| 207W00000X | Ophthalmology | E5950 (Arkansas) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Johnson Regional Medical Center | 1658360284 | 12 |
News Archive
Ray Lewis, one of the greatest players ever to step on a football field, today announced the release of an all new pre-workout intensity supplement, called Power Fuel, which will feature Lewis on its packaging and contain a powerful custom ingredient blend named in his honor.
New Phase III data found that investigational linagliptin therapy resulted in significant reductions in blood sugar as measured by hemoglobin A1c (HbA1c) when compared to placebo, both when added to sulfonylurea (SU) in inadequately controlled type 2 diabetes (T2D) patients, and when administered as monotherapy in T2D patients for whom metformin is inappropriate.
Details of a new method to detect diabetic neuropathy in patients in less than five minutes using their sweat glands was presented today at the American Association of Clinical Endocrinologists 22nd Annual Scientific and Clinical Congress in Phoenix, Arizona by Aaron I. Vinik, M.D., Ph.D., F.C.P., M.A.C.P., F.A.C.E., Professor of Medicine and Director of Research and the Neuroendocrine Unit at Eastern Virginia Medical School.
Intense blooms of toxic algae are becoming common occurrences along the coast of Florida and elsewhere.
› Verified 5 days ago
| Entity Name | Johnson Regional Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275558710 PECOS PAC ID: 1658360284 Enrollment ID: O20060824000013 |
News Archive
Ray Lewis, one of the greatest players ever to step on a football field, today announced the release of an all new pre-workout intensity supplement, called Power Fuel, which will feature Lewis on its packaging and contain a powerful custom ingredient blend named in his honor.
New Phase III data found that investigational linagliptin therapy resulted in significant reductions in blood sugar as measured by hemoglobin A1c (HbA1c) when compared to placebo, both when added to sulfonylurea (SU) in inadequately controlled type 2 diabetes (T2D) patients, and when administered as monotherapy in T2D patients for whom metformin is inappropriate.
Details of a new method to detect diabetic neuropathy in patients in less than five minutes using their sweat glands was presented today at the American Association of Clinical Endocrinologists 22nd Annual Scientific and Clinical Congress in Phoenix, Arizona by Aaron I. Vinik, M.D., Ph.D., F.C.P., M.A.C.P., F.A.C.E., Professor of Medicine and Director of Research and the Neuroendocrine Unit at Eastern Virginia Medical School.
Intense blooms of toxic algae are becoming common occurrences along the coast of Florida and elsewhere.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jo Ann Meyer, MD 517 Catalpa St, Monroe, LA 71201-7426 Ph: (318) 966-8343 | Jo Ann Meyer, MD 517 Catalpa St, Monroe, LA 71201-7426 Ph: (318) 966-8343 |
News Archive
Ray Lewis, one of the greatest players ever to step on a football field, today announced the release of an all new pre-workout intensity supplement, called Power Fuel, which will feature Lewis on its packaging and contain a powerful custom ingredient blend named in his honor.
New Phase III data found that investigational linagliptin therapy resulted in significant reductions in blood sugar as measured by hemoglobin A1c (HbA1c) when compared to placebo, both when added to sulfonylurea (SU) in inadequately controlled type 2 diabetes (T2D) patients, and when administered as monotherapy in T2D patients for whom metformin is inappropriate.
Details of a new method to detect diabetic neuropathy in patients in less than five minutes using their sweat glands was presented today at the American Association of Clinical Endocrinologists 22nd Annual Scientific and Clinical Congress in Phoenix, Arizona by Aaron I. Vinik, M.D., Ph.D., F.C.P., M.A.C.P., F.A.C.E., Professor of Medicine and Director of Research and the Neuroendocrine Unit at Eastern Virginia Medical School.
Intense blooms of toxic algae are becoming common occurrences along the coast of Florida and elsewhere.
› Verified 5 days ago
Dr. William Jason Read, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2600 Tower Dr, Suite 111, Monroe, LA 71201 Phone: 318-387-3881 Fax: 318-387-3886 | |
Dr. Gerald Ball Broussard, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1250 Pecanland Rd, Suite E-1, Monroe, LA 71203 Phone: 318-387-2015 Fax: 318-387-2097 | |
Dr. Nidhi Batra, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 1310 N 19th St, Monroe, LA 71201 Phone: 318-487-2020 | |
Dr. Richard Kurman Apt, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 1310 N 19th St, Monroe, LA 71201 Phone: 318-388-2020 | |
Dr. Joseph Boone Barron, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 3101 Mercedes Dr, Monroe, LA 71201 Phone: 318-325-2020 Fax: 318-388-0000 |